LOC729020 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.599600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.135800E-01
Normal-vs-Stage2
7.659600E-01
Normal-vs-Stage3
6.264100E-02
Normal-vs-Stage4
4.810600E-01
Stage1-vs-Stage2
7.588600E-01
Stage1-vs-Stage3
6.692300E-02
Stage1-vs-Stage4
4.634600E-01
Stage2-vs-Stage3
3.018700E-03
Stage2-vs-Stage4
5.192600E-01
Stage3-vs-Stage4
2.031200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.755400E-01
Normal-vs-AfricanAmerican
8.753000E-01
Normal-vs-Asian
8.276200E-01
Caucasian-vs-AfricanAmerican
9.799400E-01
Caucasian-vs-Asian
8.363000E-01
AfricanAmerican-vs-Asian
9.238800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.392600E-01
Normal-vs-Female
8.752200E-01
Male-vs-Female
9.389600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.863600E-01
Normal-vs-Age(41-60Yrs)
5.674000E-01
Normal-vs-Age(61-80Yrs)
9.549800E-01
Normal-vs-Age(81-100Yrs)
8.405000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.775000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.197800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.758600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.796430E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.619600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.146800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.929400E-01
Normal-vs-Daily Drinker
3.977400E-01
Normal-vs-Weekly Drinker
8.648200E-01
Normal-vs-Occasional Drinker
5.910600E-01
Normal-vs-Social Drinker
8.494800E-01
Non Drinker-vs-Daily Drinker
7.232100E-02
Non Drinker-vs-Weekly Drinker
8.585000E-01
Non Drinker-vs-Occasional Drinker
3.611400E-01
Non Drinker-vs-Social Drinker
9.498800E-01
Daily Drinker-vs-Weekly Drinker
2.121600E-01
Daily Drinker-vs-Occasional Drinker
1.588320E-02
Daily Drinker-vs-Social Drinker
7.517900E-02
Weekly Drinker-vs-Occasional Drinker
6.232000E-01
Weekly Drinker-vs-Social Drinker
9.123000E-01
Occasional Drinker-vs-Social Drinker
4.504400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.821400E-01
Normal-vs-Grade 2
9.484000E-02
Normal-vs-Grade 3
7.775700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.755600E-03
Grade 1-vs-Grade 3
2.839700E-04
Grade 1-vs-Grade 4
2.821400E-01
Grade 2-vs-Grade 3
6.546100E-02
Grade 2-vs-Grade 4
9.484000E-02
Grade 3-vs-Grade 4
7.775700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.781800E-01
Normal-vs-NonDiabetic
9.462800E-01
Diabetic-vs-NonDiabetic
7.673600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.762000E-01
Normal-vs-NoPancreatitis
9.164200E-01
Pancreatitis-vs-NoPancreatitis
5.507400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.957600E-01
Normal-vs-N1
7.471000E-01
N0-vs-N1
1.186410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.654000E-01
Normal-vs-TP53-NonMutant
5.739600E-01
TP53-Mutant-vs-TP53-NonMutant
3.414800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
